Formule complète
Formule complète, licence 80097222: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nova-Pharma
- NPN or DIN-HM
- 80097222
- Status
- Active licence
- Licence date
- 21 February 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 27 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 27 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Pyridoxine | 9.0 mg | 27,000 µg |
| Pantothenic acid Source : Acide D-pantothénique | 10.0 mg | 30,000 µg |
| Niacinamide Source : Niacinamide | 20.0 mg | Not calculated |
| Zinc Source : Diglycinate de zinc | 0.7 mg | 2,100 µg |
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : Ribose | 6.5 mg | Not calculated |
| Potassium Source : Citrate de potassium | 12.76 mg | 38,280 µg |
| Vitamine C Source : Acide ascorbique | 6.0 mg | 18,000 µg |
| Sodium Source : Chlorure de sodium | 20.0 mg | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 1.0 mg AT | Not calculated |
| (2R,3R)-2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphényl)-4H-1-benzopyran-4-one Source : Dihydromyricetin | 100.0 mg | Not calculated |
| Folate Source : Acide folique | 0.33 mg | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 65.0 mcg EAR | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 3.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve digestive upset including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia, and flatulent colic (carminative). Hepatoprotectant/ liver protectant. Help(s) to support liver function. Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia Helps in energy production. Helps in energy metabolism and tissue formation. Helps to maintain the body's ability to metabolize nutrients. Helps to form red blood cells. Helps with immune function. Source of electrolytes. Helps to maintain healthy metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs.
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Contre-indications
Consult a health care practitioner/health care provider/health care professional /doctor/ physician prior to use if you are pregnant.
Source
Official Health Canada record, licence 80097222
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.